Literature DB >> 21557533

Macrophage activation syndrome revealing familial Mediterranean fever.

L Rossi-Semerano1, B Hermeziu, M Fabre, I Koné-Paut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21557533     DOI： 10.1002/acr.20418

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  10 in total

1.  The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.

Authors:  Sebastian Fn Bode; Sandra Ammann; Waleed Al-Herz; Mihaela Bataneant; Christopher C Dvorak; Stephan Gehring; Andrew Gennery; Kimberly C Gilmour; Luis I Gonzalez-Granado; Ute Groß-Wieltsch; Marianne Ifversen; Jenny Lingman-Framme; Susanne Matthes-Martin; Rolf Mesters; Isabelle Meyts; Joris M van Montfrans; Jana Pachlopnik Schmid; Sung-Yun Pai; Pere Soler-Palacin; Uta Schuermann; Volker Schuster; Markus G Seidel; Carsten Speckmann; Polina Stepensky; Karl-Walter Sykora; Bianca Tesi; Thomas Vraetz; Catherine Waruiru; Yenan T Bryceson; Despina Moshous; Kai Lehmberg; Michael B Jordan; Stephan Ehl
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

Review 2.  Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Authors:  Lauren A Henderson; Randy Q Cron
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

Review 3.  Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.

Authors:  Donato Rigante; Giacomo Emmi; Michele Fastiggi; Elena Silvestri; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-08       Impact factor: 3.650

4.  MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages.

Authors:  K Fujikawa; K Migita; Y Shigemitsu; M Umeda; F Nonaka; M Tamai; H Nakamura; A Mizokami; T Tsukada; T Origuchi; N Yonemitsu; M Yasunami; A Kawakami; K Eguchi
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

5.  Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease.

Authors:  Raheleh Assari; Vahid Ziaee; Arash Mirmohammadsadeghi; Mohammad-Hassan Moradinejad
Journal:  Dis Markers       Date:  2015-04-30       Impact factor: 3.434

6.  Toward an Inclusive, Congruent, and Precise Definition of Autoinflammatory Diseases.

Authors:  Per Wekell; Stefan Berg; Anna Karlsson; Anders Fasth
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

Review 7.  Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.

Authors:  Mehmet Soy; Gökhan Keser; Pamir Atagündüz; Fehmi Tabak; Işık Atagündüz; Servet Kayhan
Journal:  Clin Rheumatol       Date:  2020-05-30       Impact factor: 2.980

Review 8.  Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges.

Authors:  Fares E M Ali; Zuhair M Mohammedsaleh; Mahmoud M Ali; Osama M Ghogar
Journal:  World J Gastroenterol       Date:  2021-04-21       Impact factor: 5.742

9.  Hemophagocytic lymphohistiocytosis and pelger-huët anomaly associated with colchicine intoxication.

Authors:  Baris Malbora; Emine Polat; Sare Gulfem Akyuz
Journal:  Hematol Rep       Date:  2014-06-19

Review 10.  The off-label use of anakinra in pediatric systemic autoinflammatory diseases.

Authors:  Valerio Maniscalco; Sarah Abu-Rumeileh; Maria Vincenza Mastrolia; Edoardo Marrani; Ilaria Maccora; Ilaria Pagnini; Gabriele Simonini
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-10-16       Impact factor: 5.346
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.